
Embolic prevention system is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.
Highlights
The global Embolic Prevention Systems market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Embolic Prevention Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Embolic Prevention Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Embolic Prevention Systems in Cardiovascular Diseases is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Embolic Prevention Systems include Medtronic, Abbott, InspireMD and Boston Scientific, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Embolic Prevention Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolic Prevention Systems.
The Embolic Prevention Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Embolic Prevention Systems market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolic Prevention Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Medtronic
Abbott
InspireMD
Boston Scientific
Segment by Type
Distal Occlusion Devices
Distal Filters
Proximal Occlusion Devices
Segment by Application
Cardiovascular Diseases
Neurovascular Diseases
Peripheral Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Embolic Prevention Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Embolic Prevention Systems Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Distal Occlusion Devices
1.2.3 Distal Filters
1.2.4 Proximal Occlusion Devices
1.3 Market by Application
1.3.1 Global Embolic Prevention Systems Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cardiovascular Diseases
1.3.3 Neurovascular Diseases
1.3.4 Peripheral Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Embolic Prevention Systems Market Perspective (2018-2029)
2.2 Embolic Prevention Systems Growth Trends by Region
2.2.1 Global Embolic Prevention Systems Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Embolic Prevention Systems Historic Market Size by Region (2018-2023)
2.2.3 Embolic Prevention Systems Forecasted Market Size by Region (2024-2029)
2.3 Embolic Prevention Systems Market Dynamics
2.3.1 Embolic Prevention Systems Industry Trends
2.3.2 Embolic Prevention Systems Market Drivers
2.3.3 Embolic Prevention Systems Market Challenges
2.3.4 Embolic Prevention Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Embolic Prevention Systems Players by Revenue
3.1.1 Global Top Embolic Prevention Systems Players by Revenue (2018-2023)
3.1.2 Global Embolic Prevention Systems Revenue Market Share by Players (2018-2023)
3.2 Global Embolic Prevention Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Embolic Prevention Systems Revenue
3.4 Global Embolic Prevention Systems Market Concentration Ratio
3.4.1 Global Embolic Prevention Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Embolic Prevention Systems Revenue in 2022
3.5 Embolic Prevention Systems Key Players Head office and Area Served
3.6 Key Players Embolic Prevention Systems Product Solution and Service
3.7 Date of Enter into Embolic Prevention Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Embolic Prevention Systems Breakdown Data by Type
4.1 Global Embolic Prevention Systems Historic Market Size by Type (2018-2023)
4.2 Global Embolic Prevention Systems Forecasted Market Size by Type (2024-2029)
5 Embolic Prevention Systems Breakdown Data by Application
5.1 Global Embolic Prevention Systems Historic Market Size by Application (2018-2023)
5.2 Global Embolic Prevention Systems Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Embolic Prevention Systems Market Size (2018-2029)
6.2 North America Embolic Prevention Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Embolic Prevention Systems Market Size by Country (2018-2023)
6.4 North America Embolic Prevention Systems Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Embolic Prevention Systems Market Size (2018-2029)
7.2 Europe Embolic Prevention Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Embolic Prevention Systems Market Size by Country (2018-2023)
7.4 Europe Embolic Prevention Systems Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Embolic Prevention Systems Market Size (2018-2029)
8.2 Asia-Pacific Embolic Prevention Systems Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Embolic Prevention Systems Market Size by Region (2018-2023)
8.4 Asia-Pacific Embolic Prevention Systems Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Embolic Prevention Systems Market Size (2018-2029)
9.2 Latin America Embolic Prevention Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Embolic Prevention Systems Market Size by Country (2018-2023)
9.4 Latin America Embolic Prevention Systems Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Embolic Prevention Systems Market Size (2018-2029)
10.2 Middle East & Africa Embolic Prevention Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Embolic Prevention Systems Market Size by Country (2018-2023)
10.4 Middle East & Africa Embolic Prevention Systems Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Embolic Prevention Systems Introduction
11.1.4 Medtronic Revenue in Embolic Prevention Systems Business (2018-2023)
11.1.5 Medtronic Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Embolic Prevention Systems Introduction
11.2.4 Abbott Revenue in Embolic Prevention Systems Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 InspireMD
11.3.1 InspireMD Company Detail
11.3.2 InspireMD Business Overview
11.3.3 InspireMD Embolic Prevention Systems Introduction
11.3.4 InspireMD Revenue in Embolic Prevention Systems Business (2018-2023)
11.3.5 InspireMD Recent Development
11.4 Boston Scientific
11.4.1 Boston Scientific Company Detail
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Embolic Prevention Systems Introduction
11.4.4 Boston Scientific Revenue in Embolic Prevention Systems Business (2018-2023)
11.4.5 Boston Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Medtronic
Abbott
InspireMD
Boston Scientific
Ìý
Ìý
*If Applicable.
